Publications by authors named "Radu Leonte"

Claim this Profile
I
IVA Prime: automated primer design for in vivo assembly cloning.
Radu Cristian Leonte, Patrick David Fischer, Beatriz Herguedas, Javier García-Nafría, Sebastian Hiller

Nucleic Acids Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zr-Radiolabelling of p-NCS-Bz-DFO-Anti-HER2 Affibody Immunoconjugate: Characterization and Assessment of In Vitro Potential in HER2-Positive Breast Cancer Imaging.
Maria-Roxana Tudoroiu-Cornoiu, Radu Marian Șerban, Diana Cocioabă, Dragoș Andrei Niculae, Doina Drăgănescu, Radu Leonte

Pharmaceutics· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized production of Zr as a medical radioisotope on a variable energy cyclotron and external beam-line.
Diana Cocioabă, Simona Baruta, Liviu Crăciun, Radu Leonte, Andrei Necsoiu

EJNMMI Phys· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotensin (8-13) and Neuromedin N Neuropeptides Radiolabelling with Copper-64 Produced on Solid or Liquid Targets.
Diana Cocioabă, Alexandra I Fonseca, Radu Leonte, Ivanna Hrynchak, Roxana Tudoroiu-Cornoiu

Molecules· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody and Nanobody Radiolabeling with Copper-64: Solid vs. Liquid Target Approach.
Ivanna Hrynchak, Diana Cocioabă, Alexandra I Fonseca, Radu Leonte, Sérgio J C do Carmo

Molecules· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifications in cellular viability, DNA damage and stress responses inflicted in cancer cells by copper-64 ions.
Radu M Serban, Dana Niculae, Gina Manda, Ionela Neagoe, Maria Dobre, Radu A Leonte

Front Med (Lausanne)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with Ga and Lu as Potential Theranostic Agent for Colon Cancer.
Radu Anton Leonte, Livia Elena Chilug, Radu Șerban, Cosmin Mustăciosu, Alina Raicu

Pharmaceutics· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Evaluation of NHS-Activated Gold Nanoparticles Functionalized with Bombesin or Neurotensin-Like Peptides for Targeting Colon and Prostate Tumours.
Livia Elena Chilug, Dana Niculae, Radu Anton Leonte, Alexandrina Nan, Rodica Turcu

Molecules· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis